Maxwell Biosciences

Destroys Most Infections with One Nontoxic Molecule. 10 Year FDA Exclusivity on All-Cause Pneumonia.

https://wefunder.com/maxwell.biosciences

Total raised on Wefunder: 351500

Total investors: 32

Quick facts

  • FDA QIDP in bacterial & fungal pneumonia: FDA Fast Track, Priority Review, 10-yr exclusivity
  • Govt-sponsored primate study: MRSA & Candida cleared from the head in 3 days, no toxicity
  • $69M+ in funding & grants; government backing from US, Australia, India, S. Korea & Japan
  • 7 signed U.S. military R&D agreements (CRADAs) + a $3M U.S. Army MTEC award, all non-dilutive
  • Novel membrane + DNA/RNA mechanism showed no bacterial resistance across 30 lab passages
  • Backed by 500+ peer-reviewed published studies; published in-vivo efficacy, safety and no resistance
  • A platform, not one drug: AI designs Claromers that mimic the body's own immune peptides
  • Board includes Eli Lilly President, Ret. U.S. Army biodefense commanding General, former Congressman

Team profiles

Featured investor profiles

Maxwell Biosciences

Destroys Most Infections with One Nontoxic Molecule. 10 Year FDA Exclusivity on All-Cause Pneumonia.

Never miss an update

  • Join the Maxwell Biosciences community. Follow their journey as they grow.
  • Stay in the loop if they ever decide to raise a round.

Ask

Ask a Question